Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
Apply
Anti-CD38 A2 Dimeric
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step